Amy Bertha is currently Executive Director, Regulatory Policy and Innovation at Bayer. Her prior experience includes, regulatory program and project management at FDA Center for Drugs and Evaluation, regulatory affairs at Pfizer, and research scientist at Hoffman-La Roche. She is an organic chemist by training.